Sai Kiran S S Pindiprolu (Praveen Thaggikuppe Krishnamurthy, Praveen T Krishnamurthy, Sai Kiran Ss Pindiprolu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 8

Top Venues

RSC advances

Nanomedicine (London, England)

Biomaterials science

Expert opinion on drug delivery

JSS College of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

JSS College of Pharmacy Jul 14 2016

India

PHD :: Pharmacology

Publications

Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, Sai Kiran S S Pindiprolu
Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease. RSC advances 11 (10) (2021)
Ammu V V V Ravi Kiran, Garikapati Kusuma Kumari, Sai Kiran S S Pindiprolu, Renat R Khaydarov
Tumor microenvironment and nanotherapeutics: intruding the tumor fort. Biomaterials science 9 (23) (2021)
Kusuma Kumari G, Sai Kiran S S Pindiprolu, Ravi Kiran Ammu V V V, Kurawattimath Vishwanath, S T Narenderan, B Babu, Nagappan Krishnaveni
Development and validation of a sensitive LC-MS/MS method for pioglitazone: application towards pharmacokinetic and tissue distribution study in rats. RSC advances 11 (19) (2021)
Piyong Sola, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S S Pindiprolu, Mamta Kumari
Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management. Expert opinion on drug delivery 17 (8) (2020)
Sai Kiran S S Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Venkata Rao Ghanta, Pavan Kumar Chintamaneni
Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer. Nanomedicine (London, England) 15 (16) (2020)
Mantosh Kumar Singh, Sai Kiran S S Pindiprolu, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele, G N K Ganesh
Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: in vitro studies. RSC advances 9 (43) (2019)
Venkata Rao Ghanta, Nagaraju Madala, Aparna Pasula, Sai Kiran S S Pindiprolu, Kumara Swamy Battula, Praveen Thaggikuppe Krishnamurthy, Balamurali Raman
Novel dermacozine-1-carboxamides as promising anticancer agents with tubulin polymerization inhibitory activity. RSC advances 9 (32) (2019)
Sai Kiran S S Pindiprolu, Pavan Kumar Chintamaneni, Praveen Thaggikuppe Krishnamurthy, Kinnera Ratna Sree Ganapathineedi
Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug development and industrial pharmacy 45 (2) (2018)

Sai Kiran S S Pindiprolu.css-eqlu8i{font-size:small;padding-left:4px;} (Praveen Thaggikuppe Krishnamurthy, Praveen T Krishnamurthy, Sai Kiran Ss Pindiprolu)

Publication Activity (10 Years)

Top Topics

Top Venues

Sai Kiran S S Pindiprolu (Praveen Thaggikuppe Krishnamurthy, Praveen T Krishnamurthy, Sai Kiran Ss Pindiprolu)